5-Amino-1MQMetabolic Small MoleculeSafety Rating 6/10
Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.
Price Comparison
Compare vendors · per 5mg
| Vendor | Price | $ / mg | Updated | |
|---|---|---|---|---|
| Puratek PeptidesBest $/mgCOA ✓ · 3POut of stock | $49.46 | $0.99 | May 19, 2026 | Buy → |
| Petratide ScienceCOA ✓ · 3P | $54.95 | $1.10 | May 14, 2026 | Buy → |
| SomaChemsCOA ✓ · 3P | $63.99 | $1.28 | May 14, 2026 | Buy → |
| PeptiraCOA ✓ · 3P | $129.00 | $2.58 | May 14, 2026 | Buy → |
| Puratek PeptidesCOA ✓ · 3P | $31.46 | $3.15 | May 19, 2026 | Buy → |
Overview
About 5-Amino-1MQ
Mechanism of action
Selective NNMT (Nicotinamide N-methyltransferase) inhibitor; blocks NNMT from methylating NAD+ precursors; increases NAD+/NADH ratio; activates SIRT1; promotes fat cell 'browning'.
Safety profile
Research compound with limited human data. Theoretical: NAD+ metabolism disruption, GI discomfort. Generally reported as well-tolerated. · Experimental NNMT inhibitor; animal data favorable; no major safety signals identified; WADA banned
Storage
Stability & handling
🔔 Get notified when the price drops anywhere
No account required. We scan 30+ vendors daily — one email the moment any vendor drops 5-Amino-1MQ below your target.
Related pages
More on 5-Amino-1MQ
Stack & Compare
Frequently Researched Together
Research
Studies & key findings
- Small-molecule NNMT (nicotinamide N-methyltransferase) inhibitor that raises NAD+ precursor availability in adipose tissue, activating thermogenesis without caloric restriction.
- Reverses high-fat-diet-induced obesity in mice over 11 weeks, reducing fat mass and improving metabolic markers — results replicated across independent labs.